The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parker, L. C.
Right arrow Articles by Sabroe, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, L. C.
Right arrow Articles by Sabroe, I.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOHEXIMIDE
The Journal of Immunology, 2004, 172: 4977-4986.
Copyright © 2004 by The American Association of Immunologists

Toll-Like Receptor (TLR)2 and TLR4 Agonists Regulate CCR Expression in Human Monocytic Cells1

Lisa C. Parker*, Moira K. B. Whyte*, Stefanie N. Vogel{dagger}, Steven K. Dower* and Ian Sabroe2,*

* Section of Functional Genomics, Division of Genomic Medicine, University of Sheffield, Sheffield, United Kingdom; and {dagger} Department of Microbiology and Immunology, University of Maryland, Baltimore, MD 21229

Interactions between proinflammatory and cell maturation signals, and the pathways that regulate leukocyte migration, are of fundamental importance in controlling trafficking and recruitment of leukocytes during the processes of innate and adaptive immunity. We have investigated the molecular mechanisms by which selective Toll-like receptor (TLR)2 and TLR4 agonists regulate expression of CCR1 and CCR2 on primary human monocytes and THP-1 cells, a human monocytic cell line. We found that activation of either TLR2 (by Pam3CysSerLys4) or TLR4 (by purified LPS) resulted in down-modulation of both CCR1 and CCR2. Further investigation of TLR-induced down-modulation of CCR1 revealed differences in the signaling pathways activated, and chemokines generated, via the two TLR agonists. TLR2 activation caused slower induction of the NF-{kappa}B and mitogen-activated protein kinase signaling pathways and yet a much enhanced and prolonged macrophage-inflammatory protein 1{alpha} (CC chemokine ligand 3) protein production, when compared with TLR4 stimulation. Enhanced macrophage-inflammatory protein 1{alpha} production may contribute to the prolonged down-regulation of CCR1 cell surface expression observed in response to the TLR2 agonist, as preventing chemokine generation with the protein synthesis inhibitor cycloheximide, or CCR1 signaling with the receptor antagonist UCB35625, abolished TLR2- and TLR4-induced CCR1 down-modulation. This result suggests an autocrine pathway, whereby TLR activation can induce chemokine production, which then leads to homologous down-regulation of the cognate receptors. This work provides further insights into the mechanisms that regulate leukocyte recruitment and trafficking during TLR-induced inflammatory responses.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Nair, P. A. Ramaswamy, S. Ghosh, D. C. Joshi, N. Pathak, I. Siddiqui, P. Sharma, S. E. Hasnain, S. C. Mande, and S. Mukhopadhyay
The PPE18 of Mycobacterium tuberculosis Interacts with TLR2 and Activates IL-10 Induction in Macrophage
J. Immunol., November 15, 2009; 183(10): 6269 - 6281.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Gouwy, S. Struyf, H. Verbeke, W. Put, P. Proost, G. Opdenakker, and J. Van Damme
CC chemokine ligand-2 synergizes with the nonchemokine G protein-coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCL8
J. Leukoc. Biol., September 1, 2009; 86(3): 671 - 680.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. S. McKimmie, M. Moore, A. R. Fraser, T. Jamieson, D. Xu, C. Burt, N. I. Pitman, R. J. Nibbs, I. B. McInnes, F. Y. Liew, et al.
A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration
Blood, April 30, 2009; 113(18): 4224 - 4231.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. C. Parker, E. C. Prestwich, J. R. Ward, E. Smythe, A. Berry, M. Triantafilou, K. Triantafilou, and I. Sabroe
A Phosphatidylserine Species Inhibits a Range of TLR- but Not IL-1{beta}-Induced Inflammatory Responses by Disruption of Membrane Microdomains
J. Immunol., October 15, 2008; 181(8): 5606 - 5617.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. Montecucco, S. Steffens, F. Burger, G. Pelli, C. Monaco, and F. Mach
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes
J. Leukoc. Biol., October 1, 2008; 84(4): 1109 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. T. Cadman, A. Y. Abdallah, C. Voisine, A.-M. Sponaas, P. Corran, T. Lamb, D. Brown, F. Ndungu, and J. Langhorne
Alterations of Splenic Architecture in Malaria Are Induced Independently of Toll-Like Receptors 2, 4, and 9 or MyD88 and May Affect Antibody Affinity
Infect. Immun., September 1, 2008; 76(9): 3924 - 3931.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Dower, D. K. Ellis, K. Saraf, S. A. Jelinsky, and L.-L. Lin
Innate Immune Responses to TREM-1 Activation: Overlap, Divergence, and Positive and Negative Cross-Talk with Bacterial Lipopolysaccharide
J. Immunol., March 1, 2008; 180(5): 3520 - 3534.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
B. Sherry, W. W. Dai, M. L. Lesser, and H. Trachtman
Dysregulated Chemokine Receptor Expression and Chemokine-Mediated Cell Trafficking in Pediatric Patients with ESRD
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 397 - 406.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. D. G. Despriet, A. A. B. Bergen, J. E. Merriam, J. Zernant, G. R. Barile, R. T. Smith, I. A. Barbazetto, S. van Soest, A. Bakker, P. T. V. M. de Jong, et al.
Comprehensive Analysis of the Candidate Genes CCL2, CCR2, and TLR4 in Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 364 - 371.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. A. Rupprecht, C. J. Kirschning, B. Popp, S. Kastenbauer, V. Fingerle, H.-W. Pfister, and U. Koedel
Borrelia garinii Induces CXCL13 Production in Human Monocytes through Toll-Like Receptor 2
Infect. Immun., September 1, 2007; 75(9): 4351 - 4356.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
M. J. Zilliox, W. J. Moss, and D. E. Griffin
Gene Expression Changes in Peripheral Blood Mononuclear Cells during Measles Virus Infection
Clin. Vaccine Immunol., July 1, 2007; 14(7): 918 - 923.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Shahrara, C. C. Park, V. Temkin, J. W. Jarvis, M. V. Volin, and R. M. Pope
RANTES Modulates TLR4-Induced Cytokine Secretion in Human Peripheral Blood Monocytes
J. Immunol., October 15, 2006; 177(8): 5077 - 5087.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. E. Morris, L. C. Parker, J. R. Ward, E. C. Jones, M. K. B. Whyte, C. E. Brightling, P. Bradding, S. K. Dower, and I. Sabroe
Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses
FASEB J, October 1, 2006; 20(12): 2153 - 2155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Punturieri, P. Copper, T. Polak, P. J. Christensen, and J. L. Curtis
Conserved Nontypeable Haemophilus influenzae-Derived TLR2-Binding Lipopeptides Synergize with IFN-beta to Increase Cytokine Production by Resident Murine and Human Alveolar Macrophages
J. Immunol., July 1, 2006; 177(1): 673 - 680.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Park, B.-R. Je, S. Piao, S. Inamura, Y. Fujimoto, K. Fukase, S. Kusumoto, K. Soderhall, N.-C. Ha, and B. L. Lee
A Synthetic Peptidoglycan Fragment as a Competitive Inhibitor of the Melanization Cascade
J. Biol. Chem., March 24, 2006; 281(12): 7747 - 7755.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Wurfel, W. Y. Park, F. Radella, J. Ruzinski, A. Sandstrom, J. Strout, R. E. Bumgarner, and T. R. Martin
Identification of High and Low Responders to Lipopolysaccharide in Normal Subjects: An Unbiased Approach to Identify Modulators of Innate Immunity
J. Immunol., August 15, 2005; 175(4): 2570 - 2578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. E. Morris, M. K. B. Whyte, G. F. Martin, P. J. Jose, S. K. Dower, and I. Sabroe
Agonists of Toll-like Receptors 2 and 4 Activate Airway Smooth Muscle via Mononuclear Leukocytes
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 814 - 822.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.